Free Trial

Fevertree Drinks (LON:FEVR) Reaches New 12-Month Low - Time to Sell?

Fevertree Drinks logo with Consumer Defensive background

Fevertree Drinks PLC (LON:FEVR - Get Free Report) shares hit a new 52-week low on Tuesday . The company traded as low as GBX 625.50 ($7.65) and last traded at GBX 631 ($7.72), with a volume of 376361 shares. The stock had previously closed at GBX 636 ($7.78).

Fevertree Drinks Price Performance

The company has a market capitalization of £713.87 million, a PE ratio of 3,218.42, a PEG ratio of -4.51 and a beta of 1.07. The company has a current ratio of 4.11, a quick ratio of 3.21 and a debt-to-equity ratio of 5.84. The firm has a fifty day moving average of GBX 690.41 and a two-hundred day moving average of GBX 809.25.

Fevertree Drinks Company Profile

(Get Free Report)

Fevertree Drinks PLC, together with its subsidiaries, engages in the development and sale of premium mixer drinks in the United Kingdom, the United States, rest of Europe, and internationally. It offers Indian, Mediterranean, summer garden, elderflower, cucumber, damson and sloe berry, rhubarb and raspberry, aromatic, lemon, and Clementine tonic water products; pink grapefruit, soda water, raspberry and orange blossom, Mexican lime, Italian blood orange, white grape and apricot sodas; Silician, premium, and Madagascan cola and lemonades; British apple with garden mint, ginger, Sicilian lemonade, sparkling Mexican lime, Italian white grape and apricot, and light raspberry and rose lemonade softdrinks; and gingers.

Further Reading

Should You Invest $1,000 in Fevertree Drinks Right Now?

Before you consider Fevertree Drinks, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fevertree Drinks wasn't on the list.

While Fevertree Drinks currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for January 2025. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

While 2025 may not deliver massive returns, so MarketBeat analyst Chris Markoch shares his list of seven stocks primed for consistent performance.

Related Videos

3 Stocks Insiders Are Selling, But Analysts Still Love
NVIDIA Unveils Game-Changing Tech, But Stock Dips
The Future of Healthcare: 3 AI Stocks Leading the Way

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines